Icon

FYARRO - (100MG)

SIROLIMUS None
100MG
Less Than $1000 mn
None None
None None
None None
FYARRO is an mTOR inhibitor indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).
Yes
FYARRO Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.